PubMed:32338224 / 3566-3711 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T135","span":{"begin":88,"end":92},"obj":"G_3"},{"id":"T136","span":{"begin":88,"end":92},"obj":"PG_10"},{"id":"T137","span":{"begin":88,"end":92},"obj":"PR:000003622"},{"id":"T138","span":{"begin":110,"end":118},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Moreover, Battle and associates [19] also proposed to use already available recombinant ACE2 for intercepting COVID-19 and attenuating infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T18","span":{"begin":110,"end":118},"obj":"Disease"},{"id":"T19","span":{"begin":135,"end":144},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Moreover, Battle and associates [19] also proposed to use already available recombinant ACE2 for intercepting COVID-19 and attenuating infection."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T22","span":{"begin":0,"end":145},"obj":"DRI_Background"}],"text":"Moreover, Battle and associates [19] also proposed to use already available recombinant ACE2 for intercepting COVID-19 and attenuating infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T22","span":{"begin":0,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, Battle and associates [19] also proposed to use already available recombinant ACE2 for intercepting COVID-19 and attenuating infection."}